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Abstract
Asthma and chronic obstructive pulmonary disease (COPD) are characterized by airway obstruction and airflow
limitation and pose a huge burden to society. These obstructive lung diseases impact the lung physiology across
multiple biological scales. Environmental stimuli are introduced via inhalation at the organ scale, and consequently
impact upon the tissue, cellular and sub-cellular scale by triggering signaling pathways. These changes are
propagated upwards to the organ level again and vice versa. In order to understand the pathophysiology behind
these diseases we need to integrate and understand changes occurring across these scales and this is the driving
force for multiscale computational modeling.
There is an urgent need for improved diagnosis and assessment of obstructive lung diseases. Standard clinical
measures are based on global function tests which ignore the highly heterogeneous regional changes that are
characteristic of obstructive lung disease pathophysiology. Advances in scanning technology such as
hyperpolarized gas MRI has led to new regional measurements of ventilation, perfusion and gas diffusion in the
lungs, while new image processing techniques allow these measures to be combined with information from
structural imaging such as Computed Tomography (CT). However, it is not yet known how to derive clinical
measures for obstructive diseases from this wealth of new data. Computational modeling offers a powerful
approach for investigating this relationship between imaging measurements and disease severity, and
understanding the effects of different disease subtypes, which is key to developing improved diagnostic methods.
Gaining an understanding of a system as complex as the respiratory system is difficult if not impossible via
experimental methods alone. Computational models offer a complementary method to unravel the structure-
function relationships occurring within a multiscale, multiphysics system such as this. Here we review the current
state-of-the-art in techniques developed for pulmonary image analysis, development of structural models of the
respiratory system and predictions of function within these models. We discuss application of modeling techniques
to obstructive lung diseases, namely asthma and emphysema and the use of models to predict response to
therapy. Finally we introduce a large European project, AirPROM that is developing multiscale models to
investigate structure-function relationships in asthma and COPD.
Introduction
Chronic obstructive lung diseases, the most prominent
being that of asthma and chronic obstructive pulmonary
disease (COPD), are common and exert a large burden on
society [1]. These diseases affect over 500 million people
worldwide [2] with related costs exceeding €56 billion per
year in the European Union. These diseases are character-
ized by an underlying inflammatory response that encom-
pass pathophysiological changes across a range of
biological - spatial and time - scales: from gene to cell,
tissue to whole organ. The diminished lung function in
obstructive lung diseases is characterized by an underlying
inflammatory response that induces airway remodeling,
airflow limitation and increased ventilation-perfusion (V/
Q) mismatch. Whilst the hallmark of asthma is variable
airflow obstruction and airway hyper-responsiveness of
the airway smooth muscle (ASM), COPD is characterized
by permanent and irreversible airflow obstruction. Captur-
ing the physics of this system requires detailed structural
models as well as models predicting alterations in mechan-
ical properties of the tissue during disease and the
dynamics of fluid flows. It has been realized that the emer-
gent function of the lung cannot necessarily be predicted
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using a reductionist approach [3]: that is, resulting func-
tion may not be predicted realistically by considering the
component parts in isolation. It is the nonlinear interac-
tion between the parts that leads to unexpected properties;
hence the need for the development of multiscale models.
The Physiome project (http://physiomeproject.org)
started in 1997 with the aim of developing a framework for
modeling the entire human body. The Virtual Physiological
Human initiative (http://www.vph-institute.org) followed
not long after with similar goals but with a particular
emphasis on personalized medicine. These initiatives ulti-
mately aim to bridge the gaps in physiology - bringing
together data from disparate scales of biology and provid-
ing a means of interpreting or inferring alterations in regio-
nal properties across the biological scales from molecule to
organ. Technical areas being addressed around the world
as part of these initiatives include data handling, markup
languages, model repositories, ontologies, computational
tools as well as development of grid, middleware, and
workflows [4]. Probably the most developed Physiome/
VPH-type model is that of the heart. For example, cardiac
electrophysiology models have been used to computation-
ally assess drug-induced effects on the electrocardiogram;
with models linking right from ion-channels to predictions
of body surface potential [5]. Models of the respiratory sys-
tem are following closely behind developments such as this
with, for example, personalized models of airflow used to
predict the response to therapy [6-9] and multiscale models
of ventilation in the asthmatic lung [3,10,11].
The diagnosis and severity classifications of obstructive
lung diseases are largely based on global lung measure-
ments from pulmonary function tests (PFTs). However
these measures are insufficient for current diagnostic
needs because, although they can be used to attribute
future risk of disease progression, future exacerbations
and mortality in populations, they are poor predictors of
patient outcomes for individuals [12]. PFTs provide mea-
surements only of global lung function and cannot detect
the regional functional changes characteristic of lung dis-
eases. It is these heterogeneities that we need to character-
ize on a patient-specific basis in order to advance
healthcare. For this reason medical imaging is increasingly
being used in the diagnosis of lung disease, however small
airways are not visible with current imaging modalities.
For this reason a combined imaging and modeling
approach is required to obtain novel information about
the respiratory system. Imaging and image processing
techniques are critical in the construction, parameteriza-
tion and validation of patient-specific computational mod-
els. In this review, we begin by outlining current state-of-
the-art tools and techniques related to computational
modeling of the lung and pulmonary image analysis. We
describe how models have so far been applied to under-
standing or improving analysis related to obstructive lung
diseases and in providing more sensitive measures of
response to therapy. We finish by outlining the work in an
exemplar lung modeling project, AirPROM.
Computational modeling of the lung
Structural models of the lung
Early models of the lung utilized generic representations
of the structure - for example, using symmetrically
branching networks to represent airways and vessels
[13]. Rapid advancement in imaging and image proces-
sing techniques, described below, has enabled the rela-
tively straightforward generation of anatomically based
patient-specific models possible. This is important as
both experimental and simulation studies have demon-
strated the influence of geometric structure on func-
tional outcomes [14].
State-of-the-art structural models used for 3D CFD are
now fully patient specific consisting of high-resolution
computational meshes of the central airways (typically
including 7-9 generations of branching) containing in the
order of millions of computational elements [15,16]. Smal-
ler airways however are not currently represented in these
types of models due to computational and time restric-
tions on the size of the meshes. A simplified 1D approach
is necessary to represent the structure of the full airway
and vascular networks. Tawhai et al. [17] developed a
volume-filling branching (VFB) algorithm, which has pro-
vided a morphometrically-realistic method to generate
patient-specific network models, used in several modeling
studies [11,18-24]. This method generates branches from
the end points of airways/vessels derived from high-resolu-
tion images (typically CT images at full inspiration) and
grows a branching tree into the lobar volumes also derived
from imaging. Note that the central airways and lobar
volumes and shapes are patient-specific while the addi-
tional 1D branches are only an estimation of the structure
(but are realistic according to published branching statis-
tics) of the distal airway tree. 1D models require informa-
tion regarding branch diameter to be allocated and this is
normally derived from the visible CT branches plus mor-
phometric information published in the literature.
Parameterizing models from imaging
Both structural and functional information can be
extracted from imaging and used to parameterize or
validate computational models. Structural information
is becoming relatively well established in the modeling
pipeline. CT is the modality of choice for structural
lung imaging due to its high spatial resolution and
good signal-to-noise ratio [25]. The CT Hounsfield
Unit (HU) provides a measure of density and enables
extraction of structural features such as the geometry
of airways, vessels and lobes, vital for the development
of personalized models.
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Airway segmentation is commonly performed using
threshold-based region-growing methods to detect the air-
way lumen [25]. The centerline can be determined using
local properties of the image or skeletonization. The com-
putational mesh of the airway segmentation may be used
directly in 3D CFD simulations, while the centerline and
radius information are used in the development of perso-
nalized 1D functional models. The wall thickness can be
extracted and used to assess inflammation effects of
disease. Vessel segmentation has been performed using
Hessian-based approaches such as the vesselness filter [26].
Lobe segmentation is typically performed by dividing the
segmented lung volume through detection of the pulmon-
ary fissures using various methods (see review by [25]).
Some authors extend lobar segmentation ideas to extract
the pulmonary segments (see review by [25]). However,
validation is more difficult as the segment boundaries are
not generally identifiable on CT scans. A novel technique
combining imaging and modeling (via the VFB) has been
used to extract pulmonary segments within the Synergy-
COPD project (Figure 1, Doel, 2014, unpublished informa-
tion). High resolution CT data used here was provided
with permission by Hospital Clinic, IDIBAPS, University
of Barcelona using a multislice spiral CT scanner (Soma-
tom Sensation 64) as part of the Synergy-COPD project.
The regional assessment of obstructive disease can also
be used to parameterize or validate computational models.
A great deal of research has been carried out into auto-
mated assessment of COPD from CT images [27]. The
amount of emphysema, bronchial wall thickening and air-
trapping can all by quantified using CT. Emphysema is
typically quantified by computing the percentage of voxels
which fall below a simple threshold such as −950 HU.
Functional imaging offers a wealth of regional data for
model parameterization and validation. In recent years,
one of the biggest areas of development for functional
imaging of the lung has been in hyperpolarized gas MR
imaging (HP MRI) [28]. Measures of both static and
dynamic ventilation are possible, providing information on
the distribution of disease attributes such as ventilation
defects and gas trapping [29,30]. Diffusion-weighted ima-
ging measures the apparent diffusion coefficient (ADC) of
the gas and provides a measure of the alveolar structure
[31]. Increased ADC values indicate emphysema and a
increased regional heterogeneity in ADC values have been
found in both COPD and asthmatic subjects [32].
Functional models of the lung
Models of several different aspects of respiratory function
have been developed including models of ventilation
[15,18,19,33], perfusion [20,23,34], gas exchange [35],
forced expiration [36,37], gas washout [24,38], impedance
[21,22], particle transport and deposition [16,39,40] and
tissue mechanics [41,42]. Nearly all of these modeling
studies have only investigated function in a normal
healthy lung, with relatively few studies investigating
obstructive lung diseases. In this section we focus our
discussion on models representing disease and in particu-
lar multiscale models and studies that have combined
imaging and modeling methodologies.
Applications of models to bronchoconstriction/asthma
There is a paucity of truly multiscale respiratory models.
An excellent example of a multiscale model investigating
lung disease is that of Donovan et al. [10,11]. This work
has investigated the impact of bronchoconstriction on lung
function and links together events at the cellular and mole-
cular level to function in the whole organ. This model
includes patient-specific lobes and central airways and
includes distal airways created using the VFB method. The
Figure 1 Combined image-processing and modeling results from a CT scan of a patient with COPD from the Synergy-COPD project.
Segmentation of (A) central airways and (B) segments (calculated using both image processing and modeling approaches, color coded by
segment). (C) Displays emphysematous regions (emphysema indicated in white and normal tissue in brown) extracted using thresholding of the
image intensity values (emphysema <950 HU) [Doel, 2014, unpublished results].
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airway model is embedded within a ‘breathing’ mechanics
model. The tissue model for each airway is linked to a
model of the cross bridge mechanics in the ASM and their
control by calcium dynamics. This provides a link right
across the scales and has most recently been used to
demonstrate insight into the synergistic interaction
between deep inspirations and ASM cell fluidization in
reversing airway closure (linking organ level motion to cell
and tissue level function) [11].
Another example is the model developed by Venegas
et al. which incorporated an airway network, the distri-
bution of airflow, airway wall mechanics and ASM beha-
vior [3]. Only minimal heterogeneity was required in the
model (in airway wall thickness) to cause a vicious cycle
that produced a so-called catastrophic shift in airway
structure producing the self-organized patchy ventilation
observed in functional images of asthmatics. This beha-
vior would not have been observed by the simple sum-
mation of model components, the system required
interdependence between the parts to produce this
emergent outcome, highlighting the necessity of having
a fully integrated model to predict realistic outcomes.
Various other modeling studies have presented novel out-
comes through a combined imaging and modeling
approach [21,22]. These models incorporate patient-specific
airway branching geometry and in addition prescribe func-
tional defects from images. In general the structure of the
models are manipulated in order to replicate the function
observed in the images. This provides a way to infer struc-
tural properties of the small airways which cannot be mea-
sured via imaging. These studies have typically shown that
ventilation defects observed in asthmatics must be caused
by fairly severe constriction of small airways (less than
2 mm in diameter).
Applications of models to COPD/emphysema
There have been far fewer modeling studies focusing on
COPD, with most studies considering only emphysema.
Models of emphysema have predominantly focused on the
alterations occurring in the parenchymal tissue and the
resultant change in tissue mechanical properties. The most
common approach uses a network of springs to represent
the lung parenchymal tissue [43,44], with individual springs
representing alveolar walls. These modeling studies have
highlighted the redistribution of forces within the tissue
during the progression of emphysema. To initiate emphy-
sema a random percentage of springs were removed.
Additional springs under the highest tension were prefer-
entially removed to mimic mechanical failure and emphy-
sema progression. This method of progression has been
found to produce patterns of emphysema observed experi-
mentally [44] and provide important evidence for the role
of mechanical forces in emphysema progression. This
approach was extended to a larger network and revealed
sudden changes in the macroscopic stiffness of the tissue
when ‘failed’ springs connected in a continuous pathway
across the network [43]. A similar study applied a 3D
model, using cuboidal cells to represent alveoli, to investi-
gate the relationship between the pattern of alveolar wall
destruction and the emergent mechanical properties of the
tissue [45]. This study demonstrated that the distribution
of emphysematous lesions plays a vital role in the resultant
organ level function. These types of studies - linking micro-
scopic changes to macroscopic outcomes - are excellent
examples of the added knowledge computational modeling
can provide.
Functional respiratory imaging to predict the response to
therapy
Functional Respiratory Imaging (FRI) combines the com-
putational modeling technique of 3D CFD with imaging to
create patient-specific models of lung function. Pioneering
studies by FLUIDDA, a small company based in Belgium,
have applied this technique to provide a novel tool for
phenotyping patients and monitoring the efficacy of novel
respiratory drugs [7-9]. Results from over 20 clinical trials
involving a total of 750 patients have demonstrated the
higher sensitivity of FRI outcomes, in comparison with
standard diagnostic measures such as spirometry, through
its use of regional FRI biomarkers.
CT images at full inspiration and full expiration are
required for this technique. Segmentation techniques are
applied to extract the lobar volumes and central airway
geometry. Patient-specific geometric models are created
of the central airways and the patient-specific change in
lobar volume from expiration to inspiration are applied
in the CFD flow boundary conditions [15]. FRI is able to
produce clinically relevant patient specific biomarkers
such as the lobar and airway volumes, internal airflow
distribution, airway resistance, lobar perfusion and regio-
nal aerosol deposition (see Figure 2).
Multiscale models of asthma and COPD: the
AirPROM approach
In this section we will discuss a large European-wide pro-
ject called AirPROM (Airway disease PRedicting Out-
comes through patient-specific computational Modeling;
http://www.airprom.eu) [46]. This is an excellent exemplar
of the development of multiscale models of the lung
applied to obstructive lung disease that relates well to the
Synergy-COPD study (discussed in this supplement [47]).
The ultimate goal of AirPROM is to bring together data
and computational models across disparate scales to
develop an integrated multiscale model of the airways in
order to unravel the pathophysiological mechanisms occur-
ring in asthma and COPD. The modeling within this pro-
ject is clinically driven pushing modeling developments in
the direction of tangible clinical outputs. Two of the
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significant assets of AirPROM are the large amounts of
well-characterized clinical data and the truly multidiscipli-
narity of the consortium with expertise in clinical medicine,
physiology, radiology, image analysis, bioengineering, data
handling, computational modeling and systems biology.
The concept behind this work is to move away from the
typical ‘one size fits all’ treatment of respiratory disease
towards patient stratification and personalized medicine.
The clinical data consists of both asthmatic and COPD
patients from aligned consortia EvA [48], UBIOPRED [49]
and BTS Severe Asthma network [50]. These data include
extensive genomic, transcriptomic and proteomic profiles,
detailed lung function with novel small airway physiologi-
cal measures [51], bronchial challenge studies, CT [52]
and HP MRI imaging data, and patient-reported out-
comes. The data provides both cross-sectional and longi-
tudinal follow-up data including some clinical intervention
studies. These data have been integrated into a data man-
agement platform that will feed into the computational
modeling framework [53]. This is the same knowledge
management framework developed and used within the
Synergy-COPD project.
The main focus of the modeling within AirPROM is pre-
dicting ventilation and the impact of pathophysiological
changes on resultant ventilation and lung function. The
AirPROM workflow (Figure 3) includes data and models
for both the large and small airways. State-of-the-art soft-
ware (Mimics®, Materialise NV, Belgium; Airways, Institut
Telecom, France) is being developed to enable automatic
extraction of the morphological properties of central air-
ways and lobes from patient CT data. High-resolution com-
putational meshes of the central airways and lung surface
are generated for use in 3D CFD (FRI) simulation studies
using the ANSYS software. 1D airway models are generated
down to the gas exchange level using the VFB algorithm
(see Figure 4). Functional models that predict ventilation
and impedance within the 1D networks have been devel-
oped. Correlation of model predictions with imaging and
measures at the mouth will be used for model validation.
At least 70 patient specific models will be analyzed in this
pipeline. So far 24 patients within the AirPROM database
have been analyzed using FRI, results have shown a good
correlation with PFT measurements [54].
A combined HP MRI measurement and modeling
approach is being used to assess the structure and func-
tion of the small airways [55]. In addition measurements
of impedance and gas washout are being extracted from
the AirPROM patients to provide information about the
small airways. A micro-airway model is being developed,
in parallel with an ex vivo tissue model, that incorporates
tissue level mechanical models and cell level modeling
techniques (using agent-based modeling). Statistical mod-
els are being used to capture the structure and function of
the lung as a whole. All of these models - large and small
airways, macro and micro scale - will be linked together to
provide a multiscale modeling framework to predict the
evolution of disease and response to clinical interventions
[46].
The challenges in moving forward
These types of modeling approaches suffer from several
limitations. The process of modeling requires several sim-
plifying assumptions of the system being modeled to enable
feasibility of solution; models will never replicate the com-
plexity of reality. However, a model need only be as compli-
cated as required to answer a specific question. It is
paramount that implications of the simplifying assumptions
used are carefully considered when analyzing outcomes and
applying models. A large part of the Physiome/VPH-related
modeling drive aims towards creating ‘patient-specific’
Figure 2 Illustration of the typical biomarkers extracted by FLUIDDA’s work which combines computational modeling with medical
imaging to produce an approach termed Functional Respiratory Imaging (FRI) [57]Reproduced with permission from FluidDA.
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models. However, only parts of a model can be persona-
lized to a given patient with many unknowns remaining
(such as tissue properties, structure of smaller airways/ves-
sels, exact values of boundary conditions to use to name a
few). In addition, the link between genetics and environ-
ment for an individual seems a near impossible feat to
include in models. Current models typically predict func-
tion at a narrow time point of life. Predictions of the longer
time scale evolution of disease will be a very difficult prop-
erty to integrate into a modeling framework. At this stage,
the power of modeling is predominantly in generating new
hypotheses that can be tested experimentally. As new
knowledge emerges models and modeling techniques
improve models will hopefully move forward in the areas
described above.
There is a pressing need for modelers and clinicians to
work ever more closely to achieve the shared goal of
patient-specific clinically relevant multiscale models.
One of the major hurdles standing in the way of compu-
tational modeling and its clinical use is lack of model
Figure 3 Schematic diagram illustrating the workflow structure within the AirPROM project. Figure courtesy of [46].
Figure 4 Example of a patient-specific model of an AirPROM subject showing central airways (red) and lung surface (gray)
segmented from CT and on the right the 1D volume-filling branching conducting airway network (Figure courtesy of Rafel Bordas,
Oxford, www.airprom.eu).
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validation. Models need to be thoroughly tested to check
the accuracy and reliability of the predictions before they
will be accepted into the clinical environment. A recent
paper by Pathmanathan and Gray [56] discusses the field
of verification, validation and uncertainty quantification
(VVUQ) and the need for this analysis to be applied to
physiological models. This technique provides a methodi-
cal way of quantifying the accuracy (and therefore the
uncertainty) in a model and will be vital in the clinical
acceptance and usage of models.
Conclusions
Here we have presented the current state-of-the-art tech-
niques in image processing and computational modeling
of the lung. A combined approach using imaging and
modeling together provides an extremely powerful tool to
assess features of lung (dys)function unable to be mea-
sured in the clinic. The AirPROM project aims to develop
multiscale models of the lung. In comparison, the
Synergy-COPD project aims at a systems approach - inte-
grating models across different organ systems in the body.
The work being conducted within the AirPROM project
will complement Synergy-COPD by contributing models
and knowledge of the function within the lung in health
and during asthma and COPD.
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